To gain insight into molecular pathways contributing to dopaminergic cell death, we used differentiated SH-SY5Y cells treated with ROT, along with the specific UPR inhibitors AMG PERK 44 and JNK V. Understanding these regulatory mechanisms in PD pathogenesis is fundamental and may lead to development of novel treatments for PD. This evidence concerns the gene MAPK8 and Parkinson disease.